 |
AstraZeneca halts nerve growth drug studyBritish drugmaker AstraZeneca has halted studies on Medi-578, which treats nerve growth, to assess data on the product further. 'We saw a reason to put a halt to the studies to evaluate the data and ascertain a sensible path forward,&# More… |
Friday 26 April 2024
